DIN 02472945 — CONTRAVE 8 MG; 90 MG
CONTRAVE is a tablet (extended-release) of Naltrexone / Bupropion marketed by BAUSCH HEALTH, CANADA INC.. The full Naltrexone / Bupropion monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02472945
- Brand name
- CONTRAVE
- Active ingredient
- Naltrexone / Bupropion
- Strength
- 8 MG; 90 MG
- Dosage form
- TABLET (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- BAUSCH HEALTH, CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Antiobesity agent (opioid antagonist + aminoketone antidepressant combination)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.